 | • レポートコード：QYR2104Z5269 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、皮膚がん診断＆治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（日光角化症（AK）、ベース細胞癌（BCC）、扁平上皮がん（SCC）、黒色腫）、用途別市場規模（病院、がん研究センター、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・皮膚がん診断＆治療の市場動向 ・企業の競争状況、市場シェア ・皮膚がん診断＆治療の種類別市場規模（日光角化症（AK）、ベース細胞癌（BCC）、扁平上皮がん（SCC）、黒色腫） ・皮膚がん診断＆治療の用途別市場規模（病院、がん研究センター、クリニック） ・皮膚がん診断＆治療の北米市場規模2016-2027（アメリカ、カナダ） ・皮膚がん診断＆治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・皮膚がん診断＆治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・皮膚がん診断＆治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・皮膚がん診断＆治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Agilent、Amgen、Aqua Pharmaceuticals、AstraZeneca、Bristol-Myers Squibb、Daiichi Sankyo、Elekta、Eli Lilly、Roche、GSK、iCAD、Bausch Health、Merck、Novartis、Pfizer、QIAGEN、Sanofi、Teva Pharmaceutical、Varian Medical Systems） ・結論 |
Market Analysis and Insights: Global Skin Cancer Diagnosis and Therapeutics Market
The global Skin Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Skin Cancer Diagnosis and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Skin Cancer Diagnosis and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Skin Cancer Diagnosis and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Skin Cancer Diagnosis and Therapeutics market.
Global Skin Cancer Diagnosis and Therapeutics Scope and Market Size
Skin Cancer Diagnosis and Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Skin Cancer Diagnosis and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Actinic Keratoses (AK)
Based cell carcinoma (BCC)
Squamous cell carcinoma (SCC)
Melanoma
Segment by Application
Hospitals
Cancer research centers
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Agilent
Amgen
Aqua Pharmaceuticals
AstraZeneca
Bristol-Myers Squibb
Daiichi Sankyo
Elekta
Eli Lilly
Roche
AstraZeneca
Bristol-Myers Squibb
Bausch Health
Merck
Novartis
Pfizer
QIAGEN
Sanofi
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Skin Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Actinic Keratoses (AK)
1.2.3 Based cell carcinoma (BCC)
1.2.4 Squamous cell carcinoma (SCC)
1.2.5 Melanoma
1.3 Market by Application
1.3.1 Global Skin Cancer Diagnosis and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Cancer research centers
1.3.4 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Skin Cancer Diagnosis and Therapeutics Market Perspective (2016-2027)
2.2 Skin Cancer Diagnosis and Therapeutics Growth Trends by Regions
2.2.1 Skin Cancer Diagnosis and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Skin Cancer Diagnosis and Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Skin Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Skin Cancer Diagnosis and Therapeutics Industry Dynamic
2.3.1 Skin Cancer Diagnosis and Therapeutics Market Trends
2.3.2 Skin Cancer Diagnosis and Therapeutics Market Drivers
2.3.3 Skin Cancer Diagnosis and Therapeutics Market Challenges
2.3.4 Skin Cancer Diagnosis and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Skin Cancer Diagnosis and Therapeutics Players by Revenue
3.1.1 Global Top Skin Cancer Diagnosis and Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Skin Cancer Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Skin Cancer Diagnosis and Therapeutics Revenue
3.4 Global Skin Cancer Diagnosis and Therapeutics Market Concentration Ratio
3.4.1 Global Skin Cancer Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Skin Cancer Diagnosis and Therapeutics Revenue in 2020
3.5 Skin Cancer Diagnosis and Therapeutics Key Players Head office and Area Served
3.6 Key Players Skin Cancer Diagnosis and Therapeutics Product Solution and Service
3.7 Date of Enter into Skin Cancer Diagnosis and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Skin Cancer Diagnosis and Therapeutics Breakdown Data by Type
4.1 Global Skin Cancer Diagnosis and Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Skin Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2022-2027)
5 Skin Cancer Diagnosis and Therapeutics Breakdown Data by Application
5.1 Global Skin Cancer Diagnosis and Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Skin Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Skin Cancer Diagnosis and Therapeutics Market Size (2016-2027)
6.2 North America Skin Cancer Diagnosis and Therapeutics Market Size by Type
6.2.1 North America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
6.3 North America Skin Cancer Diagnosis and Therapeutics Market Size by Application
6.3.1 North America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
6.4 North America Skin Cancer Diagnosis and Therapeutics Market Size by Country
6.4.1 North America Skin Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Skin Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Skin Cancer Diagnosis and Therapeutics Market Size (2016-2027)
7.2 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Type
7.2.1 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
7.3 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Application
7.3.1 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
7.4 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Country
7.4.1 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Type
8.2.1 Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Application
8.3.1 Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Region
8.4.1 Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Skin Cancer Diagnosis and Therapeutics Market Size (2016-2027)
9.2 Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Type
9.2.1 Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Application
9.3.1 Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Country
9.4.1 Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Type
10.2.1 Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Application
10.3.1 Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Country
10.4.1 Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Agilent
11.1.1 Agilent Company Details
11.1.2 Agilent Business Overview
11.1.3 Agilent Skin Cancer Diagnosis and Therapeutics Introduction
11.1.4 Agilent Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.1.5 Agilent Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Skin Cancer Diagnosis and Therapeutics Introduction
11.2.4 Amgen Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Aqua Pharmaceuticals
11.3.1 Aqua Pharmaceuticals Company Details
11.3.2 Aqua Pharmaceuticals Business Overview
11.3.3 Aqua Pharmaceuticals Skin Cancer Diagnosis and Therapeutics Introduction
11.3.4 Aqua Pharmaceuticals Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.3.5 Aqua Pharmaceuticals Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Skin Cancer Diagnosis and Therapeutics Introduction
11.4.4 AstraZeneca Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Skin Cancer Diagnosis and Therapeutics Introduction
11.5.4 Bristol-Myers Squibb Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Daiichi Sankyo
11.6.1 Daiichi Sankyo Company Details
11.6.2 Daiichi Sankyo Business Overview
11.6.3 Daiichi Sankyo Skin Cancer Diagnosis and Therapeutics Introduction
11.6.4 Daiichi Sankyo Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.6.5 Daiichi Sankyo Recent Development
11.7 Elekta
11.7.1 Elekta Company Details
11.7.2 Elekta Business Overview
11.7.3 Elekta Skin Cancer Diagnosis and Therapeutics Introduction
11.7.4 Elekta Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.7.5 Elekta Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Skin Cancer Diagnosis and Therapeutics Introduction
11.8.4 Eli Lilly Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.8.5 Eli Lilly Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche Skin Cancer Diagnosis and Therapeutics Introduction
11.9.4 Roche Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.9.5 Roche Recent Development
11.10 GSK
11.10.1 GSK Company Details
11.10.2 GSK Business Overview
11.10.3 GSK Skin Cancer Diagnosis and Therapeutics Introduction
11.10.4 GSK Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.10.5 GSK Recent Development
11.11 iCAD
11.11.1 iCAD Company Details
11.11.2 iCAD Business Overview
11.11.3 iCAD Skin Cancer Diagnosis and Therapeutics Introduction
11.11.4 iCAD Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.11.5 iCAD Recent Development
11.12 Bausch Health
11.12.1 Bausch Health Company Details
11.12.2 Bausch Health Business Overview
11.12.3 Bausch Health Skin Cancer Diagnosis and Therapeutics Introduction
11.12.4 Bausch Health Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.12.5 Bausch Health Recent Development
11.13 Merck
11.13.1 Merck Company Details
11.13.2 Merck Business Overview
11.13.3 Merck Skin Cancer Diagnosis and Therapeutics Introduction
11.13.4 Merck Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.13.5 Merck Recent Development
11.14 Novartis
11.14.1 Novartis Company Details
11.14.2 Novartis Business Overview
11.14.3 Novartis Skin Cancer Diagnosis and Therapeutics Introduction
11.14.4 Novartis Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.14.5 Novartis Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Skin Cancer Diagnosis and Therapeutics Introduction
11.15.4 Pfizer Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.15.5 Pfizer Recent Development
11.16 QIAGEN
11.16.1 QIAGEN Company Details
11.16.2 QIAGEN Business Overview
11.16.3 QIAGEN Skin Cancer Diagnosis and Therapeutics Introduction
11.16.4 QIAGEN Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.16.5 QIAGEN Recent Development
11.17 Sanofi
11.17.1 Sanofi Company Details
11.17.2 Sanofi Business Overview
11.17.3 Sanofi Skin Cancer Diagnosis and Therapeutics Introduction
11.17.4 Sanofi Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.17.5 Sanofi Recent Development
11.18 Teva Pharmaceutical
11.18.1 Teva Pharmaceutical Company Details
11.18.2 Teva Pharmaceutical Business Overview
11.18.3 Teva Pharmaceutical Skin Cancer Diagnosis and Therapeutics Introduction
11.18.4 Teva Pharmaceutical Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
11.18.5 Teva Pharmaceutical Recent Development
11.18 Varian Medical Systems
.1 Varian Medical Systems Company Details
.2 Varian Medical Systems Business Overview
.3 Varian Medical Systems Skin Cancer Diagnosis and Therapeutics Introduction
.4 Varian Medical Systems Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
.5 Varian Medical Systems Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Skin Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Actinic Keratoses (AK)
Table 3. Key Players of Based cell carcinoma (BCC)
Table 4. Key Players of Squamous cell carcinoma (SCC)
Table 5. Key Players of Melanoma
Table 6. Global Skin Cancer Diagnosis and Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Skin Cancer Diagnosis and Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Skin Cancer Diagnosis and Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Skin Cancer Diagnosis and Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Skin Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Skin Cancer Diagnosis and Therapeutics Market Share by Regions (2022-2027)
Table 12. Skin Cancer Diagnosis and Therapeutics Market Trends
Table 13. Skin Cancer Diagnosis and Therapeutics Market Drivers
Table 14. Skin Cancer Diagnosis and Therapeutics Market Challenges
Table 15. Skin Cancer Diagnosis and Therapeutics Market Restraints
Table 16. Global Skin Cancer Diagnosis and Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Skin Cancer Diagnosis and Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Skin Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Cancer Diagnosis and Therapeutics as of 2020)
Table 19. Ranking of Global Top Skin Cancer Diagnosis and Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Skin Cancer Diagnosis and Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Skin Cancer Diagnosis and Therapeutics Product Solution and Service
Table 23. Date of Enter into Skin Cancer Diagnosis and Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Skin Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Skin Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Skin Cancer Diagnosis and Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Skin Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Skin Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Skin Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Skin Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Skin Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Skin Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Skin Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Skin Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Skin Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Agilent Company Details
Table 64. Agilent Business Overview
Table 65. Agilent Skin Cancer Diagnosis and Therapeutics Product
Table 66. Agilent Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Agilent Recent Development
Table 68. Amgen Company Details
Table 69. Amgen Business Overview
Table 70. Amgen Skin Cancer Diagnosis and Therapeutics Product
Table 71. Amgen Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Amgen Recent Development
Table 73. Aqua Pharmaceuticals Company Details
Table 74. Aqua Pharmaceuticals Business Overview
Table 75. Aqua Pharmaceuticals Skin Cancer Diagnosis and Therapeutics Product
Table 76. Aqua Pharmaceuticals Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Aqua Pharmaceuticals Recent Development
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Skin Cancer Diagnosis and Therapeutics Product
Table 81. AstraZeneca Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. Bristol-Myers Squibb Company Details
Table 84. Bristol-Myers Squibb Business Overview
Table 85. Bristol-Myers Squibb Skin Cancer Diagnosis and Therapeutics Product
Table 86. Bristol-Myers Squibb Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Bristol-Myers Squibb Recent Development
Table 88. Daiichi Sankyo Company Details
Table 89. Daiichi Sankyo Business Overview
Table 90. Daiichi Sankyo Skin Cancer Diagnosis and Therapeutics Product
Table 91. Daiichi Sankyo Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Daiichi Sankyo Recent Development
Table 93. Elekta Company Details
Table 94. Elekta Business Overview
Table 95. Elekta Skin Cancer Diagnosis and Therapeutics Product
Table 96. Elekta Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Elekta Recent Development
Table 98. Eli Lilly Company Details
Table 99. Eli Lilly Business Overview
Table 100. Eli Lilly Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Eli Lilly Recent Development
Table 102. Roche Company Details
Table 103. Roche Business Overview
Table 104. Roche Skin Cancer Diagnosis and Therapeutics Product
Table 105. Roche Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 106. Roche Recent Development
Table 107. GSK Company Details
Table 108. GSK Business Overview
Table 109. GSK Skin Cancer Diagnosis and Therapeutics Product
Table 110. GSK Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 111. GSK Recent Development
Table 112. iCAD Company Details
Table 113. iCAD Business Overview
Table 114. iCAD Skin Cancer Diagnosis and Therapeutics Product
Table 115. iCAD Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 116. iCAD Recent Development
Table 117. Bausch Health Company Details
Table 118. Bausch Health Business Overview
Table 119. Bausch Health Skin Cancer Diagnosis and Therapeutics Product
Table 120. Bausch Health Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 121. Bausch Health Recent Development
Table 122. Merck Company Details
Table 123. Merck Business Overview
Table 124. Merck Skin Cancer Diagnosis and Therapeutics Product
Table 125. Merck Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 126. Merck Recent Development
Table 127. Novartis Company Details
Table 128. Novartis Business Overview
Table 129. Novartis Skin Cancer Diagnosis and Therapeutics Product
Table 130. Novartis Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 131. Novartis Recent Development
Table 132. Pfizer Company Details
Table 133. Pfizer Business Overview
Table 134. Pfizer Skin Cancer Diagnosis and Therapeutics Product
Table 135. Pfizer Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 136. Pfizer Recent Development
Table 137. QIAGEN Company Details
Table 138. QIAGEN Business Overview
Table 139. QIAGEN Skin Cancer Diagnosis and Therapeutics Product
Table 140. QIAGEN Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 141. QIAGEN Recent Development
Table 142. Sanofi Company Details
Table 143. Sanofi Business Overview
Table 144. Sanofi Skin Cancer Diagnosis and Therapeutics Product
Table 145. Sanofi Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 146. Sanofi Recent Development
Table 147. Teva Pharmaceutical Company Details
Table 148. Teva Pharmaceutical Business Overview
Table 149. Teva Pharmaceutical Skin Cancer Diagnosis and Therapeutics Product
Table 150. Teva Pharmaceutical Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 151. Teva Pharmaceutical Recent Development
Table 152. Varian Medical Systems Company Details
Table 153. Varian Medical Systems Business Overview
Table 154. Varian Medical Systems Skin Cancer Diagnosis and Therapeutics Product
Table 155. Varian Medical Systems Revenue in Skin Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 156. Varian Medical Systems Recent Development
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Skin Cancer Diagnosis and Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Actinic Keratoses (AK) Features
Figure 3. Based cell carcinoma (BCC) Features
Figure 4. Squamous cell carcinoma (SCC) Features
Figure 5. Melanoma Features
Figure 6. Global Skin Cancer Diagnosis and Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Cancer research centers Case Studies
Figure 9. Clinics Case Studies
Figure 10. Skin Cancer Diagnosis and Therapeutics Report Years Considered
Figure 11. Global Skin Cancer Diagnosis and Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Skin Cancer Diagnosis and Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Skin Cancer Diagnosis and Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Skin Cancer Diagnosis and Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Skin Cancer Diagnosis and Therapeutics Market Share by Players in 2020
Figure 16. Global Top Skin Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Cancer Diagnosis and Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Skin Cancer Diagnosis and Therapeutics Revenue in 2020
Figure 18. Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Skin Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Skin Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Skin Cancer Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Skin Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Skin Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Skin Cancer Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Skin Cancer Diagnosis and Therapeutics Market Share by Region (2016-2027)
Figure 40. China Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Skin Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Skin Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Skin Cancer Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Skin Cancer Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Agilent Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 60. Amgen Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 61. Aqua Pharmaceuticals Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 64. Daiichi Sankyo Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 65. Elekta Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 66. Eli Lilly Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 67. Roche Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 68. GSK Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 69. iCAD Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 70. Bausch Health Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 71. Merck Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 72. Novartis Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 73. Pfizer Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 74. QIAGEN Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 75. Sanofi Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 76. Teva Pharmaceutical Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 77. Varian Medical Systems Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
世界の皮膚がん診断＆治療市場規模・現状・予測（2021年-2027年） On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the exte…- 世界のメルケル細胞癌治療市場規模・現状・予測（2021年-2027年） Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor of the skin. Market Analysis and Insights: Global Merkel Cell Carcinoma Therapeutics Market The global Merkel Cell Carcinoma Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…
- 世界の肺がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Lung Cancer Diagnosis and Therapeutics Market The global Lung Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
- 世界の基底細胞皮膚がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Basal Cell Skin Cancer Treatment Market The global Basal Cell Skin Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
- 世界の基底細胞皮膚がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Basal Cell Skin Cancer Treatment Market The global Basal Cell Skin Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…